These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4391248)

  • 1. Cytochrome P-450 and drug oxidation.
    Davies DS
    Biochem J; 1969 Dec; 115(5):23P-24P. PubMed ID: 4391248
    [No Abstract]   [Full Text] [Related]  

  • 2. Interindividual differences in rates of drug oxidation in man.
    Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
    Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytochrome P-450 and its role in drug metabolism.
    Gillette JR; Davis DC; Sasame HA
    Annu Rev Pharmacol; 1972; 12():57-84. PubMed ID: 4114185
    [No Abstract]   [Full Text] [Related]  

  • 4. [P-450 cytochrome. Detoxication by liver microsomes].
    Gajdos A
    Nouv Presse Med; 1972 Jun; 1(23):1587-92. PubMed ID: 4402521
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of drug metabolism by hydroxylated metabolites: cross-inhibition and specificity.
    Soda DM; Levy G
    J Pharm Sci; 1975 Dec; 64(12):1928-31. PubMed ID: 1206483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of mixed oxygenases and nitroreductase in drug metabolism.
    Gillette JR
    Ann N Y Acad Sci; 1969 Oct; 160(2):558-70. PubMed ID: 4390499
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of oxygenated cytochrome P-450 and of cytochrome b5 in hepatic microsomal drug oxidations.
    Baron J; Hildebrandt AG; Peterson JA; Estabrook RW
    Drug Metab Dispos; 1973; 1(1):129-38. PubMed ID: 4149374
    [No Abstract]   [Full Text] [Related]  

  • 8. IV. Pharmacogenetics and drug toxicity. Variation of drug metabolism in animals and the prediction of drug action in man.
    Burns JJ
    Ann N Y Acad Sci; 1968 Jul; 151(2):959-67. PubMed ID: 4189972
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the combination of drugs. IV. Effect of 4-hydroxyantipyrine and N-acetyl-p-aminophenol on the metabolism of phenylbutazone, oxyphenbutazone and ketophenylbutazone].
    Niwa H; Nakayama T
    Yakugaku Zasshi; 1968 Jul; 88(7):838-42. PubMed ID: 5750523
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic microsomes and drug oxidation.
    Estabrook RW
    Science; 1968 Jun; 160(3834):1368-77. PubMed ID: 4385091
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between NADH and NADPH oxidation during drug metabolism.
    Sasame HA; Mitchell JR; Thorgeirsson S; Gillette JR
    Drug Metab Dispos; 1973; 1(1):150-5. PubMed ID: 4129866
    [No Abstract]   [Full Text] [Related]  

  • 12. Lead and polychlorinated biphenyls: effects on heme and drug metabolism.
    Alvares AP; Kappas A
    Drug Metab Rev; 1979; 10(1):91-106. PubMed ID: 118861
    [No Abstract]   [Full Text] [Related]  

  • 13. Interindividual differences in drug oxidation: clinical importance.
    Sjöqvist F; von Bahr C
    Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420
    [No Abstract]   [Full Text] [Related]  

  • 14. Prediction of drug oxidation rates in man: lack of correlation with serum gamma-glutamyl transpeptidase and urinary excretion of D-glucaric acid and 6 beta-hydroxycortisol.
    Smith SE; Rawlins MD
    Eur J Clin Pharmacol; 1974; 7(1):71-5. PubMed ID: 4153008
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in rabbits with experimental renal failure.
    van Peer AP; Belpaire FM; Bogaert MG
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):346-7. PubMed ID: 708161
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in uraemic rabbits.
    Van Peer AP; Belpaire FM; Bogaert MG
    J Pharm Pharmacol; 1980 Feb; 32(2):135-6. PubMed ID: 6103036
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic factors in hepatic drug oxidation.
    Kalow W; Inaba T
    Prog Liver Dis; 1976; 5():246-58. PubMed ID: 775542
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of hepatic drug oxidation and its relationship to individual differences in rates of oxidation in man.
    Davies DS; Thorgeirsson SS
    Ann N Y Acad Sci; 1971 Jul; 179():411-20. PubMed ID: 5285386
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of nifedipine on hepatic drug oxidation.
    Dickinson TH; Egan JM; Abernethy DR
    Pharmacology; 1988; 36(6):405-10. PubMed ID: 3420161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the molecular function of cytochrome P-450 during drug metabolism.
    Estabrook RW; Matsubara T; Mason JI; Werringloer J; Baron J
    Drug Metab Dispos; 1973; 1(1):98-110. PubMed ID: 4149428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.